phenylacetic acid has been researched along with Central Nervous System Neoplasms in 1 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, S | 1 |
| Serabe, B | 1 |
| Aleksic, A | 1 |
| Bomgaars, L | 1 |
| McGuffey, L | 1 |
| Dauser, R | 1 |
| Durfee, J | 1 |
| Nuchtern, J | 1 |
| Blaney, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy[NCT04937062] | Early Phase 1 | 50 participants (Anticipated) | Interventional | 2021-03-01 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for phenylacetic acid and Central Nervous System Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Central Nervous System Neoplasms; Chroma | 2001 |